A Double-blind, Placebo-controlled Trial of Donepezil Adjunctive Treatment for Cognitive Impairment in Schizophrenia
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01490567|
Recruitment Status : Unknown
Verified December 2011 by xiaofeng Guo, Central South University.
Recruitment status was: Recruiting
First Posted : December 13, 2011
Last Update Posted : December 13, 2011
|Condition or disease||Intervention/treatment||Phase|
|Impaired Cognition Schizophrenia||Drug: Donepezil Drug: placebo||Phase 4|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||80 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|
|Official Title:||Donepezil Adjunctive Treatment for Cognitive Impairment in Schizophrenia|
|Study Start Date :||June 2011|
|Estimated Primary Completion Date :||June 2012|
|Estimated Study Completion Date :||June 2012|
Placebo Comparator: placebo
Subjects will be given with a dose of 5mg/day placebo. All drugs will be administered orally.
Active Comparator: donepezil
Subjects will be given with a dose of 5 mg/day donepezil. All drugs will be administered orally.
Other Name: Donepezil hydrochloride
- Mean Change From Baseline in the Composite Score From the Cognition Assessment Battery After 12 Weeks of Treatment [ Time Frame: 12 weeks ]
- Mean Change From Baseline in Cognition Assessment scores After 12 Weeks of Treatment [ Time Frame: 12 weeks ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01490567
|the Second Xiangya Hospital of Central South University||Recruiting|
|Changsha, Hunan, China, 410011|
|Contact: Xiaofeng Guo, Doctor 86-731-85554052 email@example.com|
|Principal Investigator:||Xiaofeng Guo, doctor||Second Xiangya Hospital of Central South University|